Company Filing History:
Years Active: 2019-2020
Title: Anri Aki: Innovator in Therapeutic Antibodies
Introduction
Anri Aki is a notable inventor based in Japan, recognized for his contributions to the field of therapeutic antibodies. His work primarily focuses on developing agents that target human Orai1, which has significant implications for various medical conditions.
Latest Patents
Anri Aki currently holds a patent for the Anti-Orai1 Antibody. The purpose of this invention is to provide a therapeutic and/or prophylactic agent targeting human Orai1. This agent is intended for use in transplant rejection, immunopathies, allergic diseases, inflammatory diseases, thrombi, cancers, and more. The invention includes a medicinal composition that comprises an antibody capable of specifically recognizing human Orai1 and suppressing human T cell activation.
Career Highlights
Throughout his career, Anri Aki has focused on innovative approaches to immunotherapy. His research has the potential to transform treatment options for patients suffering from a variety of immune-related conditions.
Collaborations
Anri Aki has collaborated with notable colleagues, including Tomoaki Komai and Takako Kimura, who contribute to his research efforts.
Conclusion
Anri Aki's work in developing the Anti-Orai1 Antibody represents a significant advancement in therapeutic strategies for managing complex medical conditions. His innovative approach continues to pave the way for future research and applications in immunotherapy.